Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Erin Saricilar"'
Autor:
Joseph W, Po, Yafeng, Ma, Bavanthi, Balakrishnar, Daniel, Brungs, Farhad, Azimi, Adam, Cooper, Erin, Saricilar, Vinay, Murthy, Paul, de Souza, Therese M, Becker
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 2265
The advent of personalized medicines targeting cell signaling pathways has radically improved melanoma patient outcomes. More recently, immune-modulating therapies disrupting the PD-1/PD-L1 axis have become a powerful tool in the treatment of a range
Autor:
Joseph W, Po, Yafeng, Ma, Alison W S, Luk, David, Lynch, Bavanthi, Balakrishnar, Daniel, Brungs, Farhad, Azimi, Adam, Cooper, Erin, Saricilar, Vinay, Murthy, Paul, de Souza, Therese M, Becker
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 2265
Molecular testing of tumor biopsies allows for the identification of the key mutations driving a patient's cancer. However, this is limited to singular nodes and may not accurately reflect cancer heterogeneity. Circulating tumor cell (CTC) analyses o
Autor:
David A. Lynch, Adam Cooper, Farhad Azimi, Erin Saricilar, Therese M. Becker, Bavanthi Balakrishnar, Joseph W. Po, Alison W S Luk, Paul de Souza, Vinay Murthy, Yafeng Ma, Daniel Brungs
Publikováno v:
Methods in Molecular Biology ISBN: 9781071612040
Molecular testing of tumor biopsies allows for the identification of the key mutations driving a patient's cancer. However, this is limited to singular nodes and may not accurately reflect cancer heterogeneity. Circulating tumor cell (CTC) analyses o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::11153a3f9b5aa99fc8e3b8c8a5f400cc
https://doi.org/10.1007/978-1-0716-1205-7_21
https://doi.org/10.1007/978-1-0716-1205-7_21
Autor:
Vinay Murthy, Erin Saricilar, Daniel Brungs, Joseph W. Po, Paul de Souza, Adam Cooper, Farhad Azimi, Bavanthi Balakrishnar, Yafeng Ma, Therese M. Becker
Publikováno v:
Methods in Molecular Biology ISBN: 9781071612040
The advent of personalized medicines targeting cell signaling pathways has radically improved melanoma patient outcomes. More recently, immune-modulating therapies disrupting the PD-1/PD-L1 axis have become a powerful tool in the treatment of a range
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6a68adbd5c85107e65f658d858fb3485
https://doi.org/10.1007/978-1-0716-1205-7_17
https://doi.org/10.1007/978-1-0716-1205-7_17